Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P61619
UPID:
S61A1_HUMAN
Alternative names:
-
Alternative UPACC:
P61619; P38378; P57726; Q5JPF8; Q8N0Z4; Q8N3U3; Q8NC71; Q9BU16; Q9Y2R3
Background:
Protein transport protein Sec61 subunit alpha isoform 1 is a key component of the SEC61 channel-forming translocon complex, crucial for transporting precursor polypeptides across the endoplasmic reticulum. It plays a pivotal role in cotranslational translocation, ER membrane insertion of transmembrane proteins, and maintenance of cellular calcium homeostasis.
Therapeutic significance:
Given its involvement in Tubulointerstitial kidney disease, autosomal dominant, 5, understanding the role of Protein transport protein Sec61 subunit alpha isoform 1 could open doors to potential therapeutic strategies.